RecruitingPhase 2 / Phase 3NCT07220252
Rare condition
Pediatric multiple sclerosis
9
studies recruiting now
as of 7 Sept 2026
53
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
6 May 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT07161258
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
RecruitingNot applicableNCT07571304
Dual-Task Training in Pediatric Multiple Sclerosis
RecruitingNCT02890641
Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
RecruitingNot applicableNCT07360977
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 9 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Pediatric multiple sclerosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Pediatric multiple sclerosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (HLA-DQB1, HLA-DRB1).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).